Abstract
Systolic anterior motion (SAM) and mitral regurgitation (MR) in patients with hypertrophic obstructive cardiomyopathy (HOCM) is associated with: Venturi effect and small LV cavity. According 2011 ACCF/AHA guideline extended myoectomy is gold standard in treatment patients with HOCM, however mitral subvalvular apparatus (MSA) intervention is still unclear.
Highlights
Background/Introduction Systolic anterior motion (SAM) and mitral regurgitation (MR) in patients with hypertrophic obstructive cardiomyopathy (HOCM) is associated with: Venturi effect and small LV cavity
Between 2010 and 2014, 182 patients underwent of extended myectomy procedures. 70 patient met inclusion criteria: were randomly assigned to receive mitral subvalvular apparatus (MSA) intervention in addition to septal myectomy (MSI group; n = 36) or undergo septal myectomy only
A primary HOCM was the main indication for surgery according to 2011 ACCF/AHA guidelines
Summary
Background/Introduction Systolic anterior motion (SAM) and mitral regurgitation (MR) in patients with hypertrophic obstructive cardiomyopathy (HOCM) is associated with: Venturi effect and small LV cavity. Mitral Subvalvular Apparatus Intervention In Patients With Obstructive Hypertrophic Cardiomyopathy: does it need? A Bogachev-Prokophiev*, S Zheleznev, M Fomenko, A Pivkin, A Afanasiev, R Sharifulin, A Karaskov From World Society of Cardiothoracic Surgeons 25th Anniversary Congress, Edinburgh Edinburgh, UK.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.